481 related articles for article (PubMed ID: 17908691)
1. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling.
Martin KA; Merenick BL; Ding M; Fetalvero KM; Rzucidlo EM; Kozul CD; Brown DJ; Chiu HY; Shyu M; Drapeau BL; Wagner RJ; Powell RJ
J Biol Chem; 2007 Dec; 282(49):36112-20. PubMed ID: 17908691
[TBL] [Abstract][Full Text] [Related]
2. PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates.
Zhao Y; Biswas SK; McNulty PH; Kozak M; Jun JY; Segar L
Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1375-85. PubMed ID: 21325637
[TBL] [Abstract][Full Text] [Related]
3. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
4. The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation.
Martin KA; Rzucidlo EM; Merenick BL; Fingar DC; Brown DJ; Wagner RJ; Powell RJ
Am J Physiol Cell Physiol; 2004 Mar; 286(3):C507-17. PubMed ID: 14592809
[TBL] [Abstract][Full Text] [Related]
5. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
Veilleux A; Houde VP; Bellmann K; Marette A
Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
[TBL] [Abstract][Full Text] [Related]
6. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors.
Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484
[TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade.
Shi Y; Yan H; Frost P; Gera J; Lichtenstein A
Mol Cancer Ther; 2005 Oct; 4(10):1533-40. PubMed ID: 16227402
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of GATA-6 is required for vascular smooth muscle cell differentiation after mTORC1 inhibition.
Xie Y; Jin Y; Merenick BL; Ding M; Fetalvero KM; Wagner RJ; Mai A; Gleim S; Tucker DF; Birnbaum MJ; Ballif BA; Luciano AK; Sessa WC; Rzucidlo EM; Powell RJ; Hou L; Zhao H; Hwa J; Yu J; Martin KA
Sci Signal; 2015 May; 8(376):ra44. PubMed ID: 25969542
[TBL] [Abstract][Full Text] [Related]
9. Thrombin induces expression of FGF-2 via activation of PI3K-Akt-Fra-1 signaling axis leading to DNA synthesis and motility in vascular smooth muscle cells.
Cao H; Dronadula N; Rao GN
Am J Physiol Cell Physiol; 2006 Jan; 290(1):C172-82. PubMed ID: 16148030
[TBL] [Abstract][Full Text] [Related]
10. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.
Ning J; Clemmons DR
Mol Endocrinol; 2010 Jun; 24(6):1218-29. PubMed ID: 20363874
[TBL] [Abstract][Full Text] [Related]
11. Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors.
Shan J; Nguyen TB; Totary-Jain H; Dansky H; Marx SO; Marks AR
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):19006-11. PubMed ID: 19020099
[TBL] [Abstract][Full Text] [Related]
12. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
Khamzina L; Veilleux A; Bergeron S; Marette A
Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4.
Ding M; Xie Y; Wagner RJ; Jin Y; Carrao AC; Liu LS; Guzman AK; Powell RJ; Hwa J; Rzucidlo EM; Martin KA
Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1403-10. PubMed ID: 21454807
[TBL] [Abstract][Full Text] [Related]
14. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN.
Mourani PM; Garl PJ; Wenzlau JM; Carpenter TC; Stenmark KR; Weiser-Evans MC
Circulation; 2004 Mar; 109(10):1299-306. PubMed ID: 14993145
[TBL] [Abstract][Full Text] [Related]
15. Mammalian target of rapamycin is activated in association with myometrial proliferation during pregnancy.
Jaffer S; Shynlova O; Lye S
Endocrinology; 2009 Oct; 150(10):4672-80. PubMed ID: 19589861
[TBL] [Abstract][Full Text] [Related]
16. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
[TBL] [Abstract][Full Text] [Related]
17. Opposing Actions of AKT (Protein Kinase B) Isoforms in Vascular Smooth Muscle Injury and Therapeutic Response.
Jin Y; Xie Y; Ostriker AC; Zhang X; Liu R; Lee MY; Leslie KL; Tang W; Du J; Lee SH; Wang Y; Sessa WC; Hwa J; Yu J; Martin KA
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2311-2321. PubMed ID: 29025710
[TBL] [Abstract][Full Text] [Related]
18. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.
Liu Y; Fanburg BL
Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.
Suh JM; Song JH; Kim DW; Kim H; Chung HK; Hwang JH; Kim JM; Hwang ES; Chung J; Han JH; Cho BY; Ro HK; Shong M
J Biol Chem; 2003 Jun; 278(24):21960-71. PubMed ID: 12668683
[TBL] [Abstract][Full Text] [Related]
20. Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells.
Andreozzi F; D'Alessandris C; Federici M; Laratta E; Del Guerra S; Del Prato S; Marchetti P; Lauro R; Perticone F; Sesti G
Endocrinology; 2004 Jun; 145(6):2845-57. PubMed ID: 15001544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
